- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
- 10-K Annual report
- 10.2 Second Amendment to the Credit Agreement
- 10.5 Exchange and Service Agreement
- 10.9 Commission Arrangement
- 10.11 Form of Key Employee Secrecy and Noncompete Agreement
- 10.18 Description of Cryolife Inc Performance Based Bonus Plan
- 10.29 Form of Incentive Stock Option Agreement
- 10.30 Form of Non-qualified Stock Option Agreement
- 10.30 Form of Director Non-qualified Stock Option Plan
- 10.31 Form of Non-employee Directors Stock Option Agreement
- 10.32 Form of Incentive Stock Option Agreement
- 10.33 Form of Non-qualified Stock Option Agreement
- 10.34 Form of Restricted Stock Award Agreement
- 10.35 Form of Non-qualified Employee Stock Option Agreement
- 10.36 Form of Grant of Non-qualified Stock Options to Directors
- 10.37 Grant of Incentive Stock Option
- 21.1 Subsidiaries of Cryolife Inc
- 23.1 Consent of Deloitte & Touche LLP
- 31.1 Section 302 CEO Certification
- 31.2 Section 302 CFO Certification
- 32 Section 906 Certifications
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement No. 333-121406 of CryoLife, Inc. on Form S-3 and Registration Statement Nos. 33-83996, 33-84048, 333-03513, 333-06141, 333-34025, 333-59853, 333-59849, 333-75535, 333-47310, 333-104637 and 333-119137 of CryoLife, Inc on Form S-8 of our reports dated February 22, 2007 relating to the consolidated financial statements and financial statement schedule of CryoLife, Inc. (which i) expresses an unqualified opinion and ii) includes an explanatory paragraph relating to the October 1, 2005 adoption of Statement of Financial Accounting Standards No. 123R “Share Based Payment” which is discussed in Note 1) and management’s report of the effectiveness of internal control over financial reporting, appearing in this Annual Report on Form 10-K of CryoLife, Inc. for the year ended December 31, 2006.
DELOITTE & TOUCHE LLP
Atlanta, Georgia
February 22, 2007